A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy

2001/11/01 by Eero Varila, Torsten Wahlström, Ilkka Rauramo · 8 citations
Medicine · #Breakthrough bleeding #Endometrium #Estrogen #Family planning #Gynecology #Hormone replacement therapy (female-to-male) #Internal medicine #Levonorgestrel #Medicine #Menopause: Health Impacts and Treatments #Obstetrics #Outpatient clinic #Ovarian function and disorders #Population #Progestin #Prospective cohort study #Reproductive Health and Contraception #Surgery

paper · pdf · doi:10.1016/s0015-0282(01)02846-1

openalex publication_date 2001/11/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/26

Cited by

• Hormonal contraception and risk of endometrial cancer: a systematic review
• Pharmacology of estrogens and progestogens: influence of different routes of administration
• British Menopause Society tools for clinicians: Progestogens and endometrial protection
• Estrogens, Progestins, and Risk of Breast Cancer
• Estrogen-progestin replacement therapy: regulatory action needed. [europepmc]
• Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy. [europepmc]
• Contraception During Perimenopause: Practical Guidance. [europepmc]
• Innovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review. [europepmc]